NCT00386113View on ClinicalTrials.gov

Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly

PHASE2CompletedINTERVENTIONAL

Enrollment

74

Participants

Timeline

Start Date

October 16, 2006

Primary Completion Date

November 14, 2006

Study Completion Date

November 14, 2006

Conditions

Influenza

Interventions

BIOLOGICAL

Fluarix and adjuvanted influenza vaccine

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY